A novel β1-tubulin mutation associated with a secretion-dependent platelet hyperactivity and prothrombotic risk
Year: 2025
Type: conference-abstract
Abstract: BackgroundMicrotubules (MTs) play a crucial role in platelet biogenesis and morphology. While mutations in β1-tubulin (TUBB1) have previously been linked to macrothrombocytopenia, their effect on platelet function remains poorly understood. Our research group has identified a novel homozygous TUBB1 mutation, p.P160L, associated with thyroid dysgenesis, platelet hyperactivation, and the presence of macroplatelets.1AimsTo investigate the impact of the TUBB1 p.P160L mutation on platelet morphology and function.MethodsA knock-in mouse model harboring the Tubb1 p.P160L mutation was used to evaluate the hemostatic phenotype in vivo and in vitro. Wild-type (WT), heterozygous (HET), and homozygous (KI) mice were compared.ResultsMorphological abnormalities and MT disorganization: Despite normal platelet counts in both HET and KI mice, platelet size was significantly increased in HET and KI (WT: 5.05 fL; HET: 5.22 fL; KI: 5.37 fL; p<0.001). Electron microscopy revealed abnormal platelet morphology, with a more rounded shape and disorganized MT structure. Western blot analysis showed a significant reduction in TUBB1 expression by 23 ± 4% in HET and 43 ± 5% in KI mice compared to WT (p<0.01). MT sedimentation by ultracentrifugation demonstrated a decrease in TUBB1 incorporation into MTs by 34% in HET and 58% in KI mice relative to WT (p<0.05), indicating a detrimental effect of the Tubb1 p.P160L mutation on MT organization and platelet structure.Enhanced platelet activation: Flow cytometry analysis revealed significantly increased activation of integrin αIIbβ3 in response to convulxin, an agonist of the collagen receptor GPVI (mean fluorescence intensity increased by 39 ± 3% in HET and 123 ± 4% in KI compared to WT; p<0.001), while responses to ADP and thrombin were unchanged. Inhibition of ADP and thromboxane A2 amplification pathways normalized integrin activation. P-selectin exposure, a marker of α-granule secretion, was also significantly elevated in response to convulxin (mean fluorescence intensity increased by 20 ± 3% in HET and 53 ± 3% in KI compared to WT; p<0.001), suggesting enhanced GPVI-dependent activation and secretion in p.P160L platelets.Prothrombotic phenotype: Collagen-induced platelet aggregation was markedly increased in HET and KI mice compared to WT (WT: 22%; HET: 49%; KI: 69%). Under flow conditions in a collagen-coated perfusion chamber at arteriolar shear rates, thrombi formed by HET and KI mice were significantly larger than those from WT mice (mean fluorescence intensity: WT: 233 ± 19 AU; HET: 460 ± 76 AU; KI: 482 ± 66 AU; p<0.05). This phenotype was reversed by inhibition of ADP and thromboxane A2 pathways. Additionally, in an in vivo thrombosis model, arteriolar occlusion time was significantly shortened in HET and KI mice (WT: 38 ± 4 min; HET: 25 ± 2 min; KI: 22 ± 2 min; p<0.01), indicating a prothrombotic tendency associated with the mutation.SummaryThis study demonstrates for the first time that a mutation in TUBB1 can lead to a secretion-dependent increase in prothrombotic risk, likely due to microtubule disorganization and subsequent platelet hyperactivation.1 Stoupa A et al. TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. EMBO Mol Med. 2018;10:e9569
Source: HAL
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7205628673
